Hyperbaric Oxygen and Cancer Research
Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumours
AbstractHyperbaric oxygen (HBO) therapy is widely used as an adjunctive treatment for various pathological states, predominantly related to hypoxic and/or ischaemic conditions. It also holds promise as an approach to overcoming the problem of oxygen deficiency in the...
Hyperbaric oxygen therapy for late radiation tissue injury
Background Cancer is a significant global health problem. Radiotherapy is a treatment for many cancers and about 50% of people having radiotherapy will be long‐term survivors. Some will experience late radiation tissue injury (LRTI) developing months or years later....
Hyperbaric oxygen therapy and cancer—a review
Summary This is a review of literature concerning HBO and cancer from 2004 to 2012, concluding that HBO has beneficial effects to some types of cancer and debunking claims that HBO would cause cancer to recur. Link to Paper
Hyperbaric Oxygen Inhibits Benign and Malignant Human Mammary Epithelial Cell Proliferation
Abstract Background: Hyperbaric oxygenation (HBO) therapy is the administration of 100%-inhaled oxygen to patients at increased atmospheric pressure. Materials and methods: We used an in vitro model to examine the effects of HBO on mammary cell proliferation. Normal...
Further application of hyperbaric oxygen in prostate cancer
Abstract Hyperbaric oxygen therapy (HBOT) has been used as an adjuvant treatment for multiple pathological states, which involves hypoxic conditions. Over the past 50 years, HBOT has been recommended and used in a wide variety of medical conditions, clinically in the...
Angiogenesis and hyperbaric oxygen in the chick embryo chorioallantoic membrane
Abstract Hyperbaric Oxygen Therapy (HBOT) is increasingly applied in different areas of medical practice. The oxy-hyperbarism effects are not well understood in cancer malignancy. One unique feature of cancer is the presence of hypoxic regions that are insensitive to...
Hyperbaric oxygen therapy for late radiation-induced tissue toxicity: prospectively patient-reported outcome measures in breast cancer patients
Abstract Introduction This study examines patient reported outcome measures of women undergoing hyperbaric oxygen treatment (HBOT) after breast-conserving therapy. Method Included were 57 women treated with HBOT for late radiation-induced tissue toxicity (LRITT)...